NM_032442.3:c.4508G>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_032442.3(NEURL4):c.4508G>A(p.Arg1503Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000719 in 1,612,554 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1503W) has been classified as Uncertain significance.
Frequency
Consequence
NM_032442.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEURL4 | ENST00000399464.7 | c.4508G>A | p.Arg1503Gln | missense_variant | Exon 29 of 29 | 1 | NM_032442.3 | ENSP00000382390.2 | ||
ENSG00000261915 | ENST00000575474.1 | n.947G>A | non_coding_transcript_exon_variant | Exon 8 of 19 | 5 | ENSP00000468772.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152112Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000129 AC: 32AN: 248912 AF XY: 0.000141 show subpopulations
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1460442Hom.: 1 Cov.: 31 AF XY: 0.0000551 AC XY: 40AN XY: 726488 show subpopulations
GnomAD4 genome AF: 0.000256 AC: 39AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74308 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4508G>A (p.R1503Q) alteration is located in exon 29 (coding exon 29) of the NEURL4 gene. This alteration results from a G to A substitution at nucleotide position 4508, causing the arginine (R) at amino acid position 1503 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at